Abstract
More patients with end-stage kidney disease (ESKD) are becoming increasingly dependent on lifelong dialysis as their only means of renal replacement therapy. However, despite the improvements in dialysis techniques/procedures and care, there are still high mortality rates, which are significantly predicted by a lowered quality of life (QoL). This chapter, therefore, addresses QoL issues in ESKD. We first explore the various issues surrounding QoL in dialysis research. We then briefly review the empirical findings and limitations in this area. We end by proposing applications of QoL research in clinical settings, and examine empirical research that might potentially assist patients with decision-making for different treatment modalities.
Keywords: Quality of life, end-stage kidney disease, dialysis, haemodialysis, peritoneal dialysis, treatment modalities, clinical applications.
Related Journals
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Current Diabetes Reviews
Current Neurovascular Research
Current Respiratory Medicine Reviews
Current Pediatric Reviews
Infectious Disorders - Drug Targets
Current Stem Cell Research & Therapy
Endocrine, Metabolic & Immune Disorders - Drug Targets
Current Alzheimer Research
Current Aging Science
Related Books
Andrology: Current and Future Developments
Male Infertility: An Integrative Manual of Western and Chinese Medicine
Awake Thoracic Surgery
The Anatomical Foundations of Regional Anesthesia and Acute Pain Medicine Macroanatomy Microanatomy Sonoanatomy Functional anatomy
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents